Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05880862 · ClinicalTrials.gov registry record · Early Phase 1

Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls

A Early Phase 1 study of Urinary Incontinence and Accidental Falls, sponsored by The University of Texas Medical Branch, Galveston.

Active
Registry status
Early Phase 1
Development phase
48
Enrollment target
1
Study location

NCT05880862 is a Early Phase 1 study of Urinary Incontinence and Accidental Falls that is active but no longer recruiting, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 48 participants, below the 261-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05880862, a Early Phase 1 study of Urinary Incontinence and Accidental Falls, is active but no longer recruiting, sponsored by The University of Texas Medical Branch, Galveston.

ACTIVE NOT RECRUITING
Registry status
Early Phase 1
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to conduct a randomized pilot multi-arm clinical trial comparing a standard course of physical therapist provided pelvic floor muscle training (PFMT) to pharmacologic therapy for the treatment of urgency urinary incontinence (UUI) or Overactive Bladder (OAB) in older women at high risk of falling. The central hypotheses for this project are i) a randomized pilot multi-arm clinical trial comparing PFMT to drug treatment for UUI or OAB in older women at high risk of falling is feasible; and ii) treatment approach can influence both UI and fall related outcomes in this patient population. The main questions it aims to answer are: 1) Is a multi-arm clinical trial comparing PFMT to drug treatment for UUI or OAB in older women at high risk of falling feasible? and 2) How does treatment approach influence both OAB and fall related outcomes in this patient population? Women (16 per arm) 60 years and older with UUI or OAB who screen positive for high fall risk will be randomized to one of three standard of care treatment arms and followed for six months. The three treatment arms are i) a 12-week structured behaviorally based pelvic floor muscle training (PFMT) intervention administered by physical therapists in the outpatient physical therapy clinic; ii) a 12-week course of the beta-3 agonist, Mirabegron; and iii) a 12-week course of the antimuscarinic, Trospium Chloride. Researchers will compare study feasibility and OAB symptom related outcomes across the three groups to see if a larger clinical trial is warranted.

Interventions

  • DRUG Mirabegron
  • BEHAVIORAL Pelvic Floor Muscle Training
  • DRUG Trospium Chloride

Study Locations (1)

Texas

  • University of Texas Medical Branch at Galveston - Galveston

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2023-09-28
Est. Completion 2025-12
Phase Early Phase 1

What the Registry Record Tells You About NCT05880862

The ClinicalTrials.gov registry entry for NCT05880862 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (82% lower). The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Urinary Incontinence appearing as the primary indexed condition, and to 3 interventions - of which Mirabegron is the first listed.

NCT05880862 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05880862 about?

NCT05880862 is a clinical study titled "Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls". The goal of this study is to conduct a randomized pilot multi-arm clinical trial comparing a standard course of physical therapist provided pelvic floor muscle training (PFMT) to pharmacologic therapy for the treatment of urgency urinary incontinence (UUI) or Overactive Bladder (OAB) in older women ...

What is the current status of trial NCT05880862?

This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 48 participants. The study started on 2023-09-28. Estimated completion is 2025-12.

What conditions does trial NCT05880862 study?

This clinical trial studies the following conditions: Urinary Incontinence, Accidental Falls, Urinary Bladder, Overactive.

What interventions are being tested in trial NCT05880862?

The interventions under investigation include: Mirabegron (DRUG), Pelvic Floor Muscle Training (BEHAVIORAL), Trospium Chloride (DRUG).

Who is sponsoring clinical trial NCT05880862?

This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05880862 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Urinary Incontinence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.